Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001650664-25-000026
Filing Date
2025-03-05
Accepted
2025-03-05 16:43:12
Documents
4
Period of Report
2025-03-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1741210979.html 4  
1 FORM 4 wk-form4_1741210979.xml 4 4086
2 EX-24 powerofattorneyforsectio.htm EX-24 5334
3 GRAPHIC powerofattorneyforsectio001.jpg GRAPHIC 277733
4 GRAPHIC powerofattorneyforsectio002.jpg GRAPHIC 40500
  Complete submission text file 0001650664-25-000026.txt   449309
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Issuer) CIK: 0001650664 (see all company filings)

EIN.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address
O'Neill Gilmore Neil (Reporting) CIK: 0001742084 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37687 | Film No.: 25711928